These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2075 related articles for article (PubMed ID: 7074591)

  • 1. The female superiority in survival in clinical stage II cutaneous malignant melanoma.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1982 May; 49(9):1941-4. PubMed ID: 7074591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1980 Dec; 46(12):2731-5. PubMed ID: 7448711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulceration and prognosis in cutaneous malignant melanoma.
    McGovern VJ; Shaw HM; Milton GW; McCarthy WH
    Histopathology; 1982 Jul; 6(4):399-407. PubMed ID: 7118080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic features of tumors and the female superiority in survival from malignant melanoma.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1980 Apr; 45(7):1604-8. PubMed ID: 7370919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of a polypoid configuration in malignant melanoma.
    McGovern VJ; Shaw HM; Milton GW
    Histopathology; 1983 Sep; 7(5):663-72. PubMed ID: 6629342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
    Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
    Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in survival from cutaneous melanoma.
    Rampen FH
    Int J Dermatol; 1984 Sep; 23(7):444-52. PubMed ID: 6386712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
    Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
    J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant melanoma: prognostic indicators.
    Ahmed I
    Mayo Clin Proc; 1997 Apr; 72(4):356-61. PubMed ID: 9121184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease.
    Berdeaux DH; Meyskens FL; Parks B; Tong T; Loescher L; Moon TE
    Cancer; 1989 Apr; 63(7):1430-6. PubMed ID: 2920369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical stages of cutaneous malignant melanoma in Bulgaria.
    Troyanova P; Valerianova Z; Danon S
    Neoplasma; 2000; 47(4):257-60. PubMed ID: 11043833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in young women with cutaneous melanoma.
    Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
    Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F; Kurul S; Camlica H; Topuz E
    Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of level V malignant melanoma.
    Bear HD; Neifeld JP; Kay S
    Cancer; 1985 Mar; 55(6):1167-71. PubMed ID: 3971289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 104.